Alexander Drilon, MD, and Justin Gainor, MD, elucidate the epidemiology of non–small cell lung cancer, as well as the genetic alterations and drivers that have affected the treatment paradigm for patients.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
![](https://i.ytimg.com/vi/FwQ_BjwDpIU/maxresdefault.jpg)